Dicerna Pharmaceuticals (DRNA) PT Raised to $34 at Citi
Tweet
Share
E-mailGet Alerts DRNA Hot Sheet
Price: $38.22 --0%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Dicerna Pharmaceuticals (NASDAQ: DRNA) to $34.00 (from $33.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- MongoDB (MDB) PT Raised to $500 at Monness, Crespi, Hardt
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
